Alfred Pühler

Alfred Pühler Forty years (and counting) at the forefront of microbiology research have not dimmed Pühler's infectious enthusiasm or voracious work ethic. By Cormac Sheridan Alfred Pühler has been a powerhouse in German microbiological research—initially in the area of plant-microbe interactions and later in industrial microbiology—over the past four decades. But he actually started out in nuclear physics, obtain

Written byCormac Sheridan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

By Cormac Sheridan

Alfred Pühler has been a powerhouse in German microbiological research—initially in the area of plant-microbe interactions and later in industrial microbiology—over the past four decades. But he actually started out in nuclear physics, obtaining his first degree in that discipline from the University of Erlangen (now the University of Erlangen-Nuremberg) in his native Bavaria in 1967. Around the same time, however, his attention was pulled in a completely different direction. "I watched two television programs dealing with the discovery of the genetic code," he recalls. The informational aspects of biology implicit in that work intrigued the young physicist.

Without ever studying biology, he embarked on a PhD in microbiology at the Institute of Microbiology at Erlangen where he became one of the early pioneers of molecular biology in Germany. "I'm quite sure we were one of the first labs in Germany to do genetic engineering," he says. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies